商务合作
动脉网APP
可切换为仅中文
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that it has commenced a proposed underwritten public offering of $150 million of shares of its common stock.
加利福尼亚州卡尔斯巴德-(BUSINESS WIRE)-Alphatec Holdings,Inc.(“ATEC”)(纳斯达克:ATEC)是一家致力于彻底改变脊柱手术方法的创新解决方案提供商,今天宣布已开始提供提供1.5亿美元普通股股份的承保公众。
In connection with the proposed offering, ATEC intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock sold in the offering. All of the shares in the offering are to be sold by ATEC. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed..
关于拟议的发行,ATEC打算授予承销商30天的期权,以购买在发行中出售的普通股的额外2250万美元股份。该产品中的所有股份均由ATEC出售。该产品受市场和其他条件的约束,无法保证产品是否或何时可以完成。。
Morgan Stanley, TD Cowen, Barclays and Stifel are acting as joint book-running managers in the offering.
Morgan Stanley,TD Cowen,Barclay和Stifel正担任联合图书运营经理。
The shares of common stock are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-271336) previously filed with and declared effective by the Securities and Exchange Commission (the “SEC”). The offering will be made only by means of a written prospectus and prospectus supplement.
普通股股份是根据先前向证券交易委员会(“SEC”)提交并宣布生效的表格S-3(文件号333-271336)的货架注册声明提供的。该产品将仅通过书面IPO和IPO补充资料进行。
A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov..
有关该产品的初步IPO补充资料和随附的IPO将向SEC提交,并将在SEC网站www.SEC.gov上提供。。
When available, copies of the preliminary prospectus supplement and accompanying prospectus may also be obtained from Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022, by telephone at (833) 297-2926 or by email at prospectus_ecm@cowen.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at 1-888-603-5847 or by email at barclaysprospectus@broadridge.com..
如果有的话,还可以从摩根斯坦利获得初步承销说明书补充和随附的承销说明书的副本。注意:承销说明书部,纽约州2楼Varick Street 180号,纽约10014;Cowen and Company,LLC,599 Lexington Avenue,New York,New York 10022,by电话(833)297-2926 or email atprospectus_ecm@cowen.com; 或Barclays Capital Inc.,c/o Broadridge Financial Solutions,1155 Long Island Avenue,Edgewood,New York 11717,电话1-888-603-5847或电子邮件barclaysprospectus@broadridge.com..
This press release shall not constitute an offer to sell nor the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新闻稿不得构成出售报价,也不得征求购买报价,也不得在任何国家或管辖区销售这些证券,在注册或资格认证之前,此类报价,征求或销售将是非法的根据任何此类州或管辖区的证券法。
The offering may only be made by means of a prospectus supplement and related base prospectus..
该报价只能通过IPO补充资料和相关基本承销说明书进行。。
About ATEC
关于ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery.
ATEC通过其合资子公司Alphatec Spine,Inc.,EOS imaging S.A.S.和SafeOp Surgical,Inc。是一家医疗器械公司,致力于通过临床区分彻底改变脊柱手术的方法。ATEC的有机创新机器™ 致力于开发新方法,与公司不断扩大的AlphaInformatiX平台无缝集成,以更好地为手术提供信息,更安全,可重复地实现脊柱手术的目标。
ATEC’s vision is to be the Standard Bearer in Spine..
ATEC的愿景是成为脊柱的主力。。
Forward-Looking Statements
前瞻性声明
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.
本新闻稿包含1995年“私人证券诉讼改革法”含义内涉及风险和不确定性的“前瞻性声明”。此类声明基于管理层当前的预期,并存在许多风险和不确定性,可能导致实际结果与前瞻性声明中描述的结果大不相同。
ATEC cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement.
ATEC警告投资者,由于各种因素,无法保证实际结果或业务条件与此类前瞻性声明中预测或建议的结果不会有实质性差异。“相信”,“将会”,“应该”,“期待”,“打算”,“估计”,“期待”和“预期”这两个词的变体可以识别前瞻性陈述,但它们的缺失并不意味着一个陈述不是一个前瞻性陈述。
Forward-looking statements include, but are not limited to, the Company’s expectations regarding the completion, timing and size of the proposed public offering. Important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the proposed public offering.
前瞻性声明包括但不限于公司对拟议公开产品的完成,时间和规模的期望。可能导致实际结果与此类前瞻性陈述所表达或暗示的结果显着不同的重要因素包括但不限于与市场和其他条件相关的风险和不确定性以及与拟议公众相关的习惯性关闭条件的满意度提供。
A further list and description of these and other factors, risks and uncertainties can be found in ATEC’s most recent annual report, any subsequent quarterly and current reports, and certain other filings, filed with the SEC. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by la.
关于这些和其他因素,风险和不确定性的进一步列表和描述可以在ATEC向SEC提交的最新年度报告,任何后续季度和当前报告以及某些其他文件中找到.ATEC否认任何意图或义务更新或修改任何前瞻性声明,无论是由于新信息,未来事件还是其他原因,除非洛杉矶要求。